Sean Stewart, a former executive with JP Morgan and Perella Weinberg Partners who is accused of insider trading based on his work on several medical device transactions, lost his bid to have criminal charges dismissed from a federal court in New York. Federal prosecutors in May 2015 charged Stewart, his father Robert Stewart and a 3rd […]
Hologic picks up DiagnoCure PCA3 prostate marker assets for $4.7m
DiagnoCure said last week it sold its PCA3 prostate cancer biomarker assets to Hologic‘s (NSDQ:HOLX) subsidiary Gen-Probe for $4.7 million (C$6.5 million). The purchase is slated to include $4 million (C$5.5 million) in cash and the repurchase of 4.9 million series A convertible preferred shares of DiagnoCure held by Gen-Probe, valued at $744,229 (C$1 million). “The […]
ConMed ripe for M&A | The week in medtech M&A
Analyst: ConMed ripe for M&A spree May 19, 2015 by Fink Densford ConMed, in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter. Newitter, who upgraded CNMD shares to “outperform” and boosted the price target to $64 from $60, wrote in […]
Feds charge ex-JP Morgan exec, father in medtech insider trading scheme
Federal prosecutors in New York this week charged a father-and-son team with insider trading connected with a spate of mergers in the medical device arena.
Hologic shuffles management teams post $4B merger with Gen-Probe | MassDevice.com On Call
MASSDEVICE ON CALL — Women’s health company Hologic (NSDQ:HOLX) announced this week former Gen-Probe chairman, president & CEO Carl Hull would step down from his new post at the merged company.
Hull manned the corner office at Gen-Probe up until Hologic acquired the company in a deal worth almost $4 billion, after which he took on a role as the senior vice president and general manager of diagnostics.
Becton, Dickinson settles Gen-Probe beef
Hologic’s Gen-Probe subsidiary notches legal win over Becton, Dickinson
Layoffs: Hologic confirms cuts following $3.7B Gen-Probe merger
Hologic closes $4B Gen-Probe buyout | Wall Street Beat
Hologic touts growing 3D breast imaging sales, updates on $3.7B Gen-Probe merger | Wall Street Beat
Hologic may close Wisconsin Dx plant following $3.7B Gen-Probe merger
Massachusetts-based women’s health devices maker Hologic (NSDQ:HOLX) may shutter a Madison, Wisc. manufacturing facility, according to an internal memo obtained by the Milwaukee-Wisconsin Journal Sentinel.
The closure will "likely" take place within 18 months of closure of Hologic’s $3.7 billion Gen-Probe acquisition, according to a memo dated June 13.
